Sigilon Therapeutics, Inc. (45) | Human Resources (12)
Browse by Subcategory
Recent Contracts
-
Consulting Agreement, dated October 13, 2021, between the Company and May Orfali, M.D
(Filed With SEC on March 14, 2022)
-
Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan
(Filed With SEC on November 30, 2020)
-
Severance Waiver and Offer Letter Amendment, between Sigilon Therapeutics, Inc. and Rogerio Vivaldi Coelho, M.D., dated October 26, 2020
(Filed With SEC on November 13, 2020)
-
Sigilon Therapeutics, Inc. Amended and Restated Severance and Change in Control Policy
(Filed With SEC on November 13, 2020)
-
Sigilon Therapeutics, Inc. Non-Employee Director Compensation Policy
(Filed With SEC on November 13, 2020)
-
Consulting Agreement between Sigilon Therapeutics, Inc. and Devyn Smith, dated April 26, 2021
(Filed With SEC on August 10, 2021)
-
Form of Incentive Stock Option Agreement
(Filed With SEC on November 30, 2020)
-
Sigilon Therapeutics, Inc. 2016 Stock Option and Grant Equity Incentive Plan, as amended
(Filed With SEC on November 13, 2020)
-
Form of Incentive Stock Option Agreement under the Sigilon Therapeutics, Inc. 2016 Equity Incentive Plan
(Filed With SEC on November 13, 2020)
-
Form of Nonstatutory Stock Option Agreement under the Sigilon Therapeutics, Inc. 2016 Equity Incentive Plan
(Filed With SEC on November 13, 2020)
-
Form of Non-Chief Executive Officer Severance Waiver and Offer Letter Amendment
(Filed With SEC on November 13, 2020)
-
Sigilon Therapeutics, Inc. 2020 Cash Incentive Plan
(Filed With SEC on November 13, 2020)